November 2, 2018 - 2018 Global Summit on Genitourinary Malignancies - OncBioMune Pharmaceuticals CEO Dr. Jonathan Head presented alongside other well renowned faculty speakers at Oncology Meeting Innovations’ 2018 Global Summit on Genitourinary Malignancies. The conference was held November 1-4, 2018 at Fairmont Banff Springs hotel in Banff, Alberta, Canada. View the Presentation
February 9, 2016 - 2016 BIO CEO & Investor Conference - OncBioMune Pharmaceuticals CEO Dr. Jonathan Head presented at the 2016 BIO CEO & Investor Conference held at the Waldorf Astoria in New York City. Dr. Head’s presentation provided a corporate overview of OncBioMune and provided details on the company’s promising pipeline of drugs in development, including ProscaVax, OncBioMune’s novel vaccine in clinical trials as a new therapy for early stage prostate cancer patients. View the Presentation
October 16, 2015 - “A Phase 1 clinical trial of a therapeutic prostate cancer vaccine containing PSA/IL-2/GM-CSF in PSA defined biochemical recurrent prostate cancer patients” - presented at CRI-CIMT-EATI-AACR: Inaugural International Cancer Immunotherapy Conference: Translating Science Into Survival meeting in New York City. View the Presentation